Reply: Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

por Michlmayr, A, Bachleitner-Hofmann, T, Bergmann, M, Oehler, R
Publicado 2011

Serum-dependent processing of late apoptotic cells for enhanced efferocytosis

por Liang, Y Y, Arnold, T, Michlmayr, A, Rainprecht, D, Perticevic, B, Spittler, A, Oehler, R
Publicado 2014

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado 2010